Genmab's blockbuster Darzalex surpasses $2B in sales

Genmab's blockbuster Darzalex surpasses $2B in sales

Source: 
BioCentury
snippet: 

Genmab A/S (CSE:GEN; Pink:GMXAY) said sales of its multiple myeloma drug Darzalex daratumumab reached $2 billion in 2018, triggering a $75 million milestone payment from partner Janssen Biotech Inc.